H. pylori vaccines: Why we still don't have any

Human Vaccines

Volumn 7, Issue 11, 2011, Pages 1153-1157

  Zhang, Songhua ^a   Moise, Leonard ^b   Moss, Steven F ^a  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

Gastric cancer; Gastric immunity; Gastritis; Helicobacter pylori; Vaccination

Indexed keywords

ANTIBIOTIC AGENT; CLARITHROMYCIN; HELICOBACTER PYLORI VACCINE; METRONIDAZOLE; OMEPRAZOLE;

ANTIBIOTIC RESISTANCE; BACTERIAL GENOME; BACTERIAL TRANSMISSION; BARRETT ESOPHAGUS; CANCER MORTALITY; DISEASE ASSOCIATION; ESOPHAGEAL ADENOCARCINOMA; HEALTH CARE FINANCING; HELICOBACTER INFECTION; HIGH RISK POPULATION; HUMAN; INDIA; INFECTION CONTROL; INFECTION RISK; NONHUMAN; NOTE; PEPTIC ULCER; RISK REDUCTION; SOCIAL CLASS; STOMACH CANCER; VACCINATION; VACCINE PRODUCTION;

EID: 81855227705     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.7.11.17655     Document Type: Note

References (43)

1. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1:1311-5; PMID:6145023; DOI:10.1016/S0140-6736(84)91816-6.
2. McColl KE. Clinical practice. Helicobacter pylori infection. N Engl J Med 2010; 362:1597-604; PMID:20427808; DOI:10.1056/NEJMcp1001110.
3. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994; 61:1-241; PMID:7715068.
4. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006; 118:3030-44; PMID:16404738; DOI:10.1002/ijc.21731.
5. Tilg H, Kaser A. Gut microbiome, obesity and metabolic dysfunction. J Clin Invest 2011; 121:2126-32; PMID:21633181; DOI:10.1172/JCI58109.
6. Falush D, Wirth T, Linz B, Pritchard JK, Stephens M, Kidd M, et al. Traces of human migrations in Helicobacter pylori populations. Science 2003; 299:1582-5; PMID:12624269; DOI:10.1126/science.1080857.
7. Kim SS, Ruiz VE, Carroll JD, Moss SF. Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphoma. Cancer Lett 2011; 305:228-38; PMID:20692762; DOI:10.1016/j.canlet.2010.07.014.
8. Mourad-Baars PE, Verspaget HW, Mertens BJ, Mearin ML. Low prevalence of Helicobacter pylori infection in young children in the Netherlands. Eur J Gastroenterol Hepatol 2007; 19:213-6; PMID:17301647; DOI:10.1097/MEG. 0b013e328011050f.
9. Alm RA, Ling LS, Moir DT, King BL, Brown ED, Doig PC, et al. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature 1999; 397:176-80; PMID:9923682; DOI:10.1038/16495.
10. Peura DA, Graham DY. Helicobacter pylori: consensus reached: peptic ulcer is on the way to becoming an historic disease. Am J Gastroenterol 1994; 89:1137-9; PMID:8053422.
11. Fuccio L, Zagari RM, Eusebi LH, Laterza L, Cennamo V, Ceroni L, et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med 2009;151:121-8; PMID:19620164.
12. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, et al. A review of human carcinogens - Part B: biological agents. Lancet Oncol 2009; 10:321-2; PMID:19350698; DOI:10.1016/S1470-2045(09)70096-8.
13. Blaser MJ. Helicobacter pylori and esophageal disease: wake-up call? Gastroenterology 2010; 139:1819-22; PMID:21029801; DOI:10.1053/j.gastro.2010.10. 037.
14. Fock KM, Katelaris P, Sugano K, Ang TL, Hunt R, Talley NJ, et al. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol 2009; 24:1587-600; PMID:19788600; DOI:10.1111/j.1440-746. 2009.05982.x.
15. Malfertheiner P, Bazzoli F, Delchier JC, Celinski K, Giguere M, Riviere M, et al. Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial. Lancet 2011; 377:905-13; PMID:21345487; DOI:10.1016/S0140-6736(11)60020-2.
16. Gatta L, Vakil N, Leandro G, Di Mario F, Vaira D. Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children. Am J Gastroenterol 2009; 104:3069-79; PMID:19844205; DOI:10.1038/ajg.2009.555.
17. Algood HM, Gallo-Romero J, Wilson KT, Peek RM Jr, Cover TL. Host response to Helicobacter pylori infection before initiation of the adaptive immune response. FEMS Immunol Med Microbiol 2007; 51:577-86; PMID:17919297; DOI:10.1111/j.1574-695X.2007.00338.x.
18. Wilson KT, Crabtree JE. Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies. Gastroenterology 2007; 133:288-308; PMID:17631150; DOI:10.1053/j.gastro.2007.05. 008.
19. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20:1161-81; PMID:8827022; DOI:10.1097/00000478-199610000-00001.
20. Nurgalieva ZZ, Conner ME, Opekun AR, Zheng CQ, Elliott SN, Ernst PB, et al. B-cell and T-cell immune responses to experimental Helicobacter pylori infection in humans. Infect Immun 2005; 73:2999-3006; PMID:15845507; DOI:10.1128/IAI.73.5.2999-3006.2005.
21. Portal-Celhay C, Perez-Perez GI. Immune responses to Helicobacter pylori colonization: mechanisms and clinical outcomes. Clin Sci (Lond) 2006; 110:305-14; PMID:16464172; DOI:10.1042/CS20050232.
22. Akhiani AA, Schon K, Franzen LE, Pappo J, Lycke N. Helicobacter pylori-specific antibodies impair the development of gastritis, facilitate bacterial colonization and counteract resistance against infection. J Immunol 2004; 172:5024-33; PMID:15067084.
23. Akhiani AA. The role of type-specific antibodies in colonization and infection by Helicobacter pylori. Curr Opin Infect Dis 2005; 18:223-7; PMID:15864099; DOI:10.1097/01.qco.0000168382.86024.14.
24. Velin D, Favre L, Bernasconi E, Bachmann D, Pythoud C, Saiji E, et al. Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model. Gastroenterology 2009; 136:2237-46 e1.
25. Shi Y, Liu XF, Zhuang Y, Zhang JY, Liu T, Yin Z, et al. Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth and contribute to pathology in mice. J Immunol 2010; 184:5121-9; PMID:20351183; DOI:10.4049/jimmunol.0901115.
26. Kao JY, Zhang M, Miller MJ, Mills JC, Wang B, Liu M, et al. Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology 2010;138:1046-54; PMID:19931266; DOI:10.1053/j.gastro.2009.11.043.
27. Velin D, Michetti P. Advances in vaccination against Helicobacter pylori. Expert Rev Gastroenterol Hepatol 2010; 4:157-66; PMID:20350263; DOI:10.1586/egh.10.6.
28. Hitzler I, Becher B, Agger EM, Muller A. Dendritic cells prevent rather than promote immunity conferred by a Helicobacter vaccine using a mycobacterial adjuvant. Gastroenterology 2011; 141:186-96; PMID:21569773; DOI:10.1053/j. gastro.2011.04.009.
29. Rad R, Brenner L, Bauer S, Schwendy S, Layland L, da Costa CP, et al. CD25+/Foxp3+ T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo. Gastroenterology 2006; 131:525-37; PMID:16890606; DOI:10.1053/j.gastro.2006.05.001.
30. Czinn SJ, Blanchard T. Vaccinating against Helicobacter pylori infection. Nat Rev Gastroenterol Hepatol 2011; 8:133-40; PMID:21304478; DOI:10.1038/nrgastro.2011.1.
31. Ghiara P, Rossi M, Marchetti M, Di Tommaso A, Vindigni C, Ciampolini F, et al. Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection. Infect Immun 1997;65:4996-5002; PMID:9393788.
32. Zhou WY, Shi Y, Wu C, Zhang WJ, Mao XH, Guo G, et al. Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB/c mice model. Vaccine 2009; 27:5013-9; PMID:19446591; DOI:10.1016/j. vaccine.2009.05.009.
33. Cuenca R, Blanchard TG, Czinn SJ, Nedrud JG, Monath TP, Lee CK, et al. Therapeutic immunization against Helicobacter mustelae in naturally infected ferrets. Gastroenterology 1996; 110:1770-5; PMID:8964402; DOI:10.1053/gast.1996. v110.pm8964402.
34. Nedrud JG. Animal models for gastric Helicobacter immunology and vaccine studies. FEMS Immunol Med Microbiol 1999; 24:243-50; PMID:10378428; DOI:10.1111/j.1574-695X.1999.tb01290.x.
35. Lee CK, Soike K, Giannasca P, Hill J, Weltzin R, Kleanthous H, et al. Immunization of rhesus monkeys with a mucosal prime, parenteral boost strategy protects against infection with Helicobacter pylori. Vaccine 1999; 17:3072-82; PMID:10462242; DOI:10.1016/S0264-410X(99)00144-9.
36. Lee CK, Soike K, Hill J, Georgakopoulos K, Tibbitts T, Ingrassia J, et al. Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys. Vaccine 1999; 17:1493-505; PMID:10195786; DOI:10.1016/S0264-410X(98)00365-X.
37. Graham DY, Opekun AR, Osato MS, El-Zimaity HM, Lee CK, Yamaoka Y, et al. Challenge model for Helicobacter pylori infection in human volunteers. Gut 2004; 53:1235-43; PMID:15306577; DOI:10.1136/gut.2003.037499.
38. Malfertheiner P, Selgrad M, Wex T, Del Giudice G, Palla E, Graham D, et al. Acute infection with a Cag A positive H. pylori strain in healthy subjects-effect on symptoms and gastric physiology. Gastroenterology 2011; 140 (Suppl. 1): S86
39. Israel DA, Salama N, Krishna U, Rieger UM, Atherton JC, Falkow S, et al. Helicobacter pylori genetic diversity within the gastric niche of a single human host. Proc Natl Acad Sci USA 2001; 98:14625-30; PMID:11724955; DOI:10.1073/pnas.251551698.
40. Moss SF, Moise L, Lee DS, Kim W, Zhang S, Lee J, et al. HelicoVax: epitope-based therapeutic Helicobacter pylori vaccination in a mouse model. Vaccine 2011;29:2085-91; PMID:21236233; DOI:10.1016/j.vaccine.2010.12.130.
41. st century: a tool for decisionmaking. Washington DC National Academies Press 2000; 181-8.
42. Rupnow MF, Chang AH, Shachter RD, Owens DK, Parsonnet J. Cost-effectiveness of a potential prophylactic Helicobacter pylori vaccine in the United States. J Infect Dis 2009; 200:1311-7; PMID:19751153; DOI:10.1086/605845.
43. Malfertheiner P, Schultze V, Rosenkranz B, Kaufmann SH, Ulrichs T, Novicki D, et al. Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study. Gastroenterology 2008; 135:787-95; PMID:18619971; DOI:10.1053/j.gastro.2008.05.054.